Dr Christos Toumpanakis

Dr Christos Toumpanakis

MD PhD FRCP AGAF FEBGH

Gastroenterology

Recommended by 1 specialist
28 years of experience

Subspecialties

  • Inflammatory Bowel Diseases (IBD) such as ulcerative Colitis or Crohn's Disease
  • Irritable Bowel Syndrome (IBS)
Show more

Languages spoken

  • English
  • Greek
Show more

Registered with

  • General Medical Council: 6121373
Show more

    Consultation fees

    New appointment: £300

    Follow-up appointment: £200

    Practices worked at

    The Wellington Hospital

    St Johns Wood, London, United Kingdom, NW8 7JA
    1,440 reviews

    About

    Dr Christos TOUMPANAKIS MD, PhD, FRCP, FEBGH, AGAF is a Consultant in Gastroenterology & Neuroendocrine Tumours (NET) at the Neuroendocrine Tumour Unit – ENETS Centre of Excellence of Royal Free Hospital, London, UK, since 2007. He is also an Honorary Associate Professor at University College of London (UCL) and has been awarded 7 times, as “Top-Teacher of the Year”. He graduated from Medical School-University of Athens, Greece in 1994, obtained his Specialty Title in Gastroenterology & Hepatology in 2004, and his PhD from University of Athens in 2007. He has been involved in the area of NET since 2000. He is lecturing on a regular basis in several National & International Conferences and published > 100 original papers and Reviews.

    He is the Chair of the Advisory Board of the European Neuroendocrine Tumour Society (ENETS), co-Chair of the Post-Graduate Course of ENETS annual Conference, co-Editor of ENETS CME program, co-Author of UK and Ireland NET Society & European NET Society Guidelines, associate Editor of “Journal of Neuroendocrinology”, as well as a member of the Advisory Board of the “UK NET patients’ foundation”.

    He is leading a NET Clinical Research Group, involving Junior Doctors and UCL Medical Students in NET Clinical research projects. His main research interests include novel NET biomarkers, molecular imaging in NETs, and carcinoid heart disease. In 2014, he organized the 1st International Conference for “Carcinoid Heart Disease” in London, which led to the development of an International Network of experts, who published the first ever International management guidelines for Carcinoid Heart Disease in March 2017.

    Apart from NET, Dr Toumpanakis sees patients with all general gastrointestinal conditions including gastro-oesophageal reflux disease, celiac disease, chronic diarrhoea, Inflammatory Bowel Disease and gastrointestinal problems in patients with congenital immuno-deficiencies.

    It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

     

    Education

    • MD - Medical School University of Athens, Greece
    • PhD - Medical School University of Athens, Greece
    Read more

    Insurers

    Powered by Doctify
    Promoting trust & transparency in healthcare